Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor

BACKGROUND AND OBJECTIVES: Obesity is a global epidemic which increases the risk of the metabolic syndrome. Cathelicidin (LL-37 and mCRAMP) is an antimicrobial peptide with an unknown role in obesity. We hypothesize that cathelicidin expression correlates with obesity and modulates fat mass and hepa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Obes (Lond)
Hlavní autoři: Tran, Deanna Hoang-Yen, Tran, Diana Hoang-Ngoc, Mattai, S. Anjani, Sallam, Tamer, Ortiz, Christina, Lee, Elaine C., Robbins, Lori, Ho, Samantha, Lee, Jung Eun, Fisseha, Elizabeth, Shieh, Christine, Sideri, Aristea, Shih, David Q, Fleshner, Philip, McGovern, Dermot PB, Vu, Michelle, Hing, Tressia C., Bakirtzi, Kyriaki, Cheng, Michelle, Su, Bowei, Law, Ivy, Karagiannides, Iordanes, Targan, Stephan R., Gallo, Richard L., Li, Zhaoping, Koon, Hon Wai
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014693/
https://ncbi.nlm.nih.gov/pubmed/27163748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ijo.2016.90
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky